A. Klepfish

757 total citations
27 papers, 484 citations indexed

About

A. Klepfish is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, A. Klepfish has authored 27 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Pathology and Forensic Medicine and 7 papers in Oncology. Recurrent topics in A. Klepfish's work include Chronic Lymphocytic Leukemia Research (7 papers), Viral-associated cancers and disorders (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). A. Klepfish is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Viral-associated cancers and disorders (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). A. Klepfish collaborates with scholars based in Israel, United States and Greece. A. Klepfish's co-authors include Ami Schattner, Ronit Sarid, Simon Karpatkin, M. Alba Greco, A Berrébi, Lev Shvidel, Joshua Friedman, Monica Huszar, Joseph Ribak and José Iscovich and has published in prestigious journals such as Biochemical and Biophysical Research Communications, CHEST Journal and International Journal of Cancer.

In The Last Decade

A. Klepfish

27 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Klepfish Israel 15 147 105 102 85 85 27 484
Hisaya Nakadate Japan 21 109 0.7× 199 1.9× 67 0.7× 82 1.0× 48 0.6× 65 919
Matthew Ming Kong Shing Hong Kong 14 97 0.7× 194 1.8× 95 0.9× 21 0.2× 37 0.4× 32 515
Tahsin Yakut Türkiye 15 88 0.6× 76 0.7× 83 0.8× 23 0.3× 39 0.5× 78 762
Hiroyuki Shichino Japan 14 62 0.4× 91 0.9× 35 0.3× 40 0.5× 54 0.6× 52 485
Hee Jo Baek South Korea 13 85 0.6× 175 1.7× 52 0.5× 56 0.7× 31 0.4× 67 565
Marco Rabusin Italy 15 125 0.9× 359 3.4× 88 0.9× 168 2.0× 58 0.7× 43 818
Vassiliki Pappa Greece 15 223 1.5× 169 1.6× 193 1.9× 243 2.9× 46 0.5× 48 736
Meerim Park South Korea 16 119 0.8× 191 1.8× 66 0.6× 29 0.3× 44 0.5× 49 521
Joseph Allen Stein Israel 14 126 0.9× 89 0.8× 49 0.5× 28 0.3× 39 0.5× 35 615
Alexandra Russo Germany 12 194 1.3× 42 0.4× 60 0.6× 34 0.4× 42 0.5× 28 490

Countries citing papers authored by A. Klepfish

Since Specialization
Citations

This map shows the geographic impact of A. Klepfish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Klepfish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Klepfish more than expected).

Fields of papers citing papers by A. Klepfish

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Klepfish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Klepfish. The network helps show where A. Klepfish may publish in the future.

Co-authorship network of co-authors of A. Klepfish

This figure shows the co-authorship network connecting the top 25 collaborators of A. Klepfish. A scholar is included among the top collaborators of A. Klepfish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Klepfish. A. Klepfish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klepfish, A., et al.. (2014). Primary effusion lymphoma in the absence of HIV infection—clinical presentation and management. QJM. 108(6). 481–488. 7 indexed citations
2.
Bairey, Osnat, Rosa Ruchlemer, Yair Herishanu, et al.. (2011). Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study. Annals of Hematology. 90(10). 1123–1129. 10 indexed citations
3.
Klepfish, A., et al.. (2009). Grave's disease and acquired hyposplenism. QJM. 103(3). 195–197. 2 indexed citations
4.
Klepfish, A., et al.. (2009). Evaluating the impact of age and disease on survival of chronic lymphocytic leukaemia patients by a new method. International Journal of Clinical Practice. 63(11). 1601–1603. 1 indexed citations
5.
Klepfish, A., et al.. (2008). Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL. QJM. 101(9). 737–740. 23 indexed citations
6.
Klepfish, A., et al.. (2006). Parvovirus B19 reactivation presenting as neutropenia after rituximab treatment. European Journal of Internal Medicine. 17(7). 505–507. 16 indexed citations
7.
Grossman, Zehava, José Iscovich, Esther Azizi, et al.. (2002). Absence of Kaposi Sarcoma Among Ethiopian Immigrants to Israel Despite High Seroprevalence of Human Herpesvirus 8. Mayo Clinic Proceedings. 77(9). 905–909. 22 indexed citations
8.
Schattner, Ami, Joshua Friedman, & A. Klepfish. (2002). Thrombotic Thrombocytopenic Purpura as an Initial Presentation of Primary Sjo¨gren’s Syndrome. Clinical Rheumatology. 21(1). 57–59. 14 indexed citations
9.
Schattner, Ami, et al.. (2002). Two Patients with Arterial Thromboembolism among 311 Patients with Adenocarcinoma of the Pancreas. The American Journal of the Medical Sciences. 324(6). 335–338. 22 indexed citations
10.
Friedman, Joshua, A. Klepfish, Edward B. Miller, et al.. (2002). Agranulocytosis in Sjögren's syndrome: Two case reports and analysis of 11 additional reported cases. Seminars in Arthritis and Rheumatism. 31(5). 338–345. 13 indexed citations
11.
Sarid, Ronit, A. Klepfish, & Ami Schattner. (2002). Virology, Pathogenetic Mechanisms, and Associated Diseases of Kaposi Sarcoma-Associated Herpesvirus (Human Herpesvirus 8). Mayo Clinic Proceedings. 77(9). 941–949. 41 indexed citations
12.
Klepfish, A., Ami Schattner, Lev Shvidel, et al.. (2002). Successful Treatment of Aggressive HIV-associated Non-Hodgkin's Lymphoma with Combination Chemotherapy, Biotherapy with Rituximab and HAART: Presentation of a Therapeutic Option. Leukemia & lymphoma. 44(2). 349–351. 15 indexed citations
13.
Klepfish, A., et al.. (2001). Intranasal Tranexamic Acid Treatment for Severe Epistaxis in Hereditary Hemorrhagic Telangiectasia. Archives of Internal Medicine. 161(5). 767–767. 36 indexed citations
14.
Klepfish, A., Ami Schattner, M Shtalrid, et al.. (2000). Advanced Hodgkin's disease in a pregnant HIV seropositive woman: Favorable mother and baby outcome following combined anticancer and antiretroviral therapy. American Journal of Hematology. 63(1). 57–58. 12 indexed citations
15.
Shvidel, Lev, et al.. (1998). Epidemiology and ethnic aspects of B cell chronic lymphocytic leukemia in Israel. Leukemia. 12(10). 1612–1617. 12 indexed citations
16.
Klepfish, A., et al.. (1997). Affinity Modulation in Platelet α2β1 Following Ligand Binding. Biochemical and Biophysical Research Communications. 232(3). 724–727. 18 indexed citations
17.
Schattner, Ami, A. Klepfish, & Avraham Caspi. (1996). Chronic Aortic Dissection Presenting as a Prolonged Febrile Disease and Arterial Embolization. CHEST Journal. 110(4). 1111–1114. 15 indexed citations
18.
Klepfish, A., M. Alba Greco, & Simon Karpatkin. (1993). Thrombin stimulates melanoma tumor‐cell binding to endothelial cells and subendothelial matrix. International Journal of Cancer. 53(6). 978–982. 76 indexed citations
19.
Lugassy, Gilles, A. Klepfish, & Alain Berrébi. (1989). Recurrent Thrombophlebitis Due to Protein C Deficiency after Splenectomy for Immune Thrombocytopenic Purpura. Acta Haematologica. 82(3). 154–155. 2 indexed citations
20.
Ribak, Joseph, et al.. (1982). Altitude and hypoxia as phase shift inducers.. PubMed. 53(4). 342–6. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hisaya Nakadate Breakdown of academic impact, for papers by Matthew Ming Kong Shing Breakdown of academic impact, for papers by Tahsin Yakut Breakdown of academic impact, for papers by Hiroyuki Shichino Breakdown of academic impact, for papers by Hee Jo Baek Breakdown of academic impact, for papers by Marco Rabusin Breakdown of academic impact, for papers by Vassiliki Pappa Breakdown of academic impact, for papers by Meerim Park Breakdown of academic impact, for papers by Joseph Allen Stein Breakdown of academic impact, for papers by Alexandra Russo
Rankless by CCL
2026